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Abstract: Cancer light-triggered hyperthermia mediated by nanomaterials aims to eliminate cancer
cells by inducing localized temperature increases to values superior to 42 ◦C, upon irradiation with a
laser. Among the different nanomaterials with photothermal capacity, the gold-based nanoparticles
have been widely studied due to their structural plasticity and advantageous physicochemical
properties. Herein, a novel and straightforward methodology was developed to produce gold
nanoclusters coated with mesoporous silica (AuMSS), using glutathione (GSH) to mediate the
formation of the gold clusters. The obtained results revealed that GSH is capable of triggering and
control the aggregation of gold nanospheres, which enhanced the absorption of radiation in the
NIR region of the spectra. Moreover, the produced AuMSS nanoclusters mediated a maximum
temperature increase of 20 ◦C and were able to encapsulate a drug model (acridine orange). In
addition, these AuMSS nanoclusters were also biocompatible with both healthy (fibroblasts) and
carcinogenic (cervical cancer) cells, at a maximum tested concentration of 200 µg/mL. Nevertheless,
the AuMSS nanoclusters’ NIR light-triggered heat generation successfully reduced the viability of
cervical cancer cells by about 80%. This confirms the potential of the AuMSS nanoclusters to be
applied in cancer therapy, namely as theragnostic agents.
Keywords: cancer; gold silica shell nanoparticles; photothermal therapy; nanoclusters; glutathione
1. Introduction
The development of nanomaterials for mediating the heat generation in response to
laser irradiation has been widely explored in the literature as a stand-alone anticancer
therapeutic approach [1–3]. Cancer photothermal therapy (PTT) aims to eliminate cancer
cells by increasing the temperature above 42 ◦C through nanomaterials activation with a
tumor-specific laser irradiation [4,5]. This also benefits from the nanomaterials specificity
towards the tumor tissue to confine the generated heat within this area [6]. Moreover,
the use of near-infrared (NIR; 750–1000 nm) light as a trigger for the photothermal ther-
apy avoids the radiation interaction with the different biological constituents achieving
a high tissue penetration [7,8]. In this way, several types of nanomaterials, such as those
based on gold, carbon (e.g., carbon nanotubes, nanographene oxide), copper, tungsten,
iron and molybdenum, have been under extensive study to mediate the cancer photother-
mal therapy [9–14]. Among them, the unique physicochemical properties of gold-based
nanomaterials highly support their application as promising photothermal therapeutic
agents [7,15]. These nanomaterials can present different structural organizations (e.g.,
spheres, rods, cages, shells and clusters) and sizes, which can be optimized to present
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a strong NIR absorption and high photothermal capacity by fine-tuning the localized
surface plasmon resonance (LSPR) phenomenon [7,12,16,17]. The gold nanoclusters result
from the gold nanospheres’ aggregation, linkage or formation in close proximity and have
been explored to increase the applicability of gold nanospheres in cancer therapy [7,18,19].
Some of the most common strategies are based on the entrapment of gold nanospheres in
large templates such as Albumin and PLGA-based nanoparticles or even the utilization
of crosslinking spacer-arms [20–22]. This structural arrangement promotes the coupling
of the plasmon oscillations between the adjacent gold nanospheres, which can lead to an
enhanced absorption in the NIR region [23]. Additionally, recent data also demonstrated
that a mesoporous silica shell can increase the photostability (i.e., prevents the degradation
or reshaping) of gold nanoparticles, without impacting their photothermal potential due
to the NIR light transparency [24–27]. Moreover, the silica shell mesopores also provide
a reservoir for loading therapeutic agents, enabling the development of combinatorial
chemo-PTT anticancer approaches [28–30]. Nevertheless, most of the protocols used for the
production of gold nanocluster are laborious and complex involving the use of spacer-arms
to attach various gold spheres, large templates to entrap the gold nanospheres, or its
encapsulation in polymeric or liposomal nanoparticles [20,21,31].
Herein, a novel and straightforward methodology was developed to produce gold
nanoclusters coated with a mesoporous silica shell (AuMSS) using glutathione (GSH) to
mediate the aggregation of gold nanospheres. In this process, both the concentration of
GSH and the source of silica (tetraethyl orthosilicate (TEOS)) were optimized, leading to the
formation of several nanoaggregate formulations. The GSH is a tripeptide (cysteine, glycine
and glutamic acid) with antioxidant properties and is essential for the maintenance of cellu-
lar redox homeostasis [32]. Moreover, it is well documented the gold affinity to molecules
composed of thiol functional groups [33]. Therefore, the establishment of gold-thiol inter-
actions can allow the GSH to act as a molecular bridge triggering the gold nanospheres
aggregation. In fact, Chegel and coworkers reported that compounds containing amine
and thiol functional groups (e.g., cysteine, urea, tris(hydroxymethyl)aminomethane and
ethanolamine) can trigger the aggregation of gold nanoparticles [34]. Similarly, Stobiecka
and colleagues also demonstrated that the interaction of citrate-capped gold nanoparticles
with homocysteine, cysteine and GSH can lead to the formation of particles’ agglomer-
ates [35–37]. Otherwise, reports available in the literature also indicate that the silica shell
can also impact the physicochemical properties of gold nanoparticles [38,39]. For that
purpose, the AuMSS nanoclusters’ potential for mediating the cancer PTT was assessed by
determining the physicochemical properties, cytocompatibility and photothermal capacity.
Moreover, the AuMSS nanoclusters drug loading capacity and release profile at pH 7.4 and
5.6 were also characterized.
2. Materials and Methods
2.1. Materials
Hydrogen tetrachloroaurate (III) trihydrate (HAuCl4·3H2O–99.9% (metals basis), Au
49% min) was obtained from Alfa Aesar (Germany). Acridine orange (AO; >98%) was
obtained from Carbosynth (Berkshire, UK). Tetraethyl orthosilicate (TEOS; >97%), tetrahy-
drofuran anhydrous (THF) stabilized with BHT and hexadecyltrimethylammonium bro-
mide (CTAB; 98%) were acquired from Tokyo Chemical Industry (Tokyo, Japan). Dul-
becco’s Modified Eagle medium-high glucose (DMEM-HG), Dulbecco’s Modified Eagle
Medium/Nutrient Mixture F-12 (DMEM-F12), phosphate-buffered saline solution (PBS),
ethanol (EtOH), Hydrochloric acid, formaldehyde, trypsin, resazurin and glutathione (GSH)
reduced were purchased from Sigma-Aldrich (Sintra, Portugal). Fetal bovine serum (FBS)
was obtained from Biochrom AG (Berlin, Germany). Calcein acetozxmethyl (calcein-AM)
and propidium iodide (PI) were obtained from Invitrogen (Carlsbad, CA, USA). Human
negroid cervix epithelioid carcinoma (HeLa cells) (ATCCs CCL-2TM) were acquired from
ATCC (Middlesex, UK). Primary normal human dermal fibroblast (FibH) cells were bought
from Promocell (Heidelberg, Germany). Cell culture t-flasks were acquired from Orange
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Scientific (Braine-l’Alleud, Belgium). Double deionized and filtered water (ultrapure water)
was obtained by using a Milli-Q Advantage A10 Ultrapure Water Purification System
(0.22 µm filtered; 18.2 MΩ cm at 25 ◦C). Cell imaging plates were acquired from Ibidi
GmbH (Munich, Germany).
2.2. Synthesis of AuMSS Nanoclusters
The synthesis of gold nanospheres was accomplished by adapting a method described
by Dias and colleagues [40]. For that purpose, 1 mL of formaldehyde (3.7 wt%) was added
to a round-bottom flask containing 24 mL of ultrapure water, 50 mg of CTAB, 0.8 mL
of HAuCl4·3H2O (0.05 M) and NaOH (0.5 M). After 15 min at 80 ◦C, the solution was
centrifuged for 20 min at 14,000× g to recover the gold nanospheres and resuspended in
ultrapure water. Then, the gold nanospheres aggregation was promoted by adding different
volumes (3; 3.5; 4; 4.5; 5 mL) of GSH solution at 6.13 mg/mL to the gold nanospheres
and stirring for 90 min. The resulting gold nanoclusters were recovered by centrifugation
(11,000× g for 20 min), resuspended in ultrapure water and reacted for 2 h with 0.2 mL
of TEOS (33% v/v in ethanol), 4.56 mg of CTAB and 17.5 µL NaOH (0.5 M). The AuMSS
nanoclusters were defined as Formula A, B, C, D and E, for the nanomaterials produced
with 3, 3.5, 4, 4.5 and 5 mL of GSH, respectively.
From the previous formulations, the two that presented the best results in TEM and
UV-Vis-NIR characterization (3.5 mL and 5 mL of GSH formulations) were used to opti-
mize the mesoporous silica shell. For that purpose, the previously described methodology
was adapted by adjusting the amount of TEOS solution added during the synthesis 0.200,
0.100, or 0.050 mL (please see Table S1). Lastly, the AuMSS nanoclusters were resus-
pended in hydrochloric acid 7.5% v/v in ethanol, sonicated for 1 min and centrifuged
(18,000× g, 20 min at 25 ◦C) to remove the CTAB [41]. After the final washing step, the
AuMSS nanoclusters were resuspended in ultrapure water.
2.3. Characterization of Nanocarriers’ Physicochemical Properties
The structure and morphology of AuMSS nanoclusters were characterized by Trans-
mission Electron Microscopy (TEM-Hitachi-HT7700, Tokyo, Japan), at an accelerating
voltage of 80 kV. Moreover, the size and zeta potential of the AuMSS nanoclusters were
evaluated using a Zetasizer Nano ZS (Malvern Instruments, Worcestershire, UK). The UV-
Vis-NIR spectra were acquired at 300 nm/min scanning rate and a wavelength range from
300 to 1100 nm in a UV-Vis-NIR spectrophotometer (Thermo Scientific Evolution™ 201 Bio
UV-Vis-NIR Spectrophotometer, Thermo Fisher Scientific Inc., Waltham, MA, USA). All the
spectra were acquired using the AuMSS nanoclusters at a concentration of 100 µg/mL.
The drug loading capacity was evaluated by immersing the AuMSS nanoclusters in
an acridine orange (AO) methanol solution for 48 h. The AO-loaded AuMSS nanoclusters
were centrifuged and the AO concentration was determined by measuring the supernatant
absorbance and using the following calibration curve (Abs = 0.1981C − 0.0033; R2 = 0.999).
Subsequently, Equation (1) was used to calculate the AO encapsulation efficiency (E.E):
E.E. (%) =
(Initial drug weight − Drug weight in the supernatant)
Initial drug weight
× 100, (1)
The AO release profile was characterized at pH 7.4 and 5.6. For that purpose, Float-
A-Lyzer dialysis bags were filled with a PBS solution containing AO-loaded AuMSS
nanoclusters and dialyzed against PBS at 37 ◦C. At different time points, 1 mL of the dialysis
media was recovered and replaced with fresh PBS, maintaining the volume constant during
the 48 h of the experiment. Finally, the released AO was quantified by measuring the media
absorbance as described above.
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2.4. In Vitro Photothermal Measurements
The photothermal potential of AuMSS nanoclusters was evaluated in vitro upon irra-
diation with a NIR laser (808 nm, 1.7 W cm−2) for 10 min and monitoring the temperature
variations using a thermocouple sensor (accuracy of 0.1 ◦C) [42].
2.5. Cytocompatibility Assay
The AuMSS nanoclusters’ cytocompatibility was assessed in both HeLa (cervical
cancer cell model) and FibH (Human fibroblasts) cells using the resazurin-based assay [43].
For that purpose, HeLa or FibH cells were cultured at a density of 10,000 cells per well
in 96-well plates for 48 h, at 37 ◦C. Then, the medium was removed and the cells were
incubated with different concentrations of AuMSS nanoclusters (from 50 to 200 µg/mL).
After 24, 48 and 72 h of incubation, the medium was replaced and the cells were incubated
with 110 µL of resazurin 10% (v/v). The cell viability was determined by measuring the
resorufin fluorescence at λex = 560 nm and λem = 590 nm. Negative control (K−)-cells
incubated only with culture media; positive control (K+)-cells incubated with EtOH.
2.6. Characterization of the Nanoclusters Phototherapeutic Effect
The AuMSS nanoclusters NIR-triggered cytotoxic activity was determined via re-
sazurin assay upon 1 or 3 irradiations cycles with NIR light. Briefly, HeLa cells were
cultured in 96-well plates at a cell density of 10,000 cells per well. Then, HeLa cells were
incubated with AuMSS nanoclusters (Formula F, G, H and I) for 6 h and submitted to 1
or 3 NIR laser (808 nm, 1.7 W cm−2 for 5 min) irradiation cycles. After 24 h of incubation
with AuMSS nanoclusters, the HeLa cells were incubated with resazurin and the viability
was assessed as described above. Negative control (K−)-cells incubated only with culture
media; positive control (K+)-cells incubated with EtOH.
Additionally, the Live/Dead assay (Invitrogen, Life Technologies, Carlsbad, CA, USA)
was also used to evaluate the cytotoxic capacity of the AuMSS nanoclusters. Briefly,
HeLa cells were cultured on µ-Slide 8 well Ibidi imaging plates (Ibidi GmbH, Gräfelfing,
Germany) and after 24 h incubated with the AuMSS nanoclusters (Formula F, G, H and I)
at a concentration of 200 µg/mL. Then, the different groups were irradiated with the laser
(808 nm, 1.7 W cm−2) for 5 min and stained with Calcein AM (live cells) and PI (dead cells).
The live/death images were obtained by Confocal Laser Scanning Microscopy (CLSM;
Zeiss LSM 710, Carl Zeiss AG, Jena, Germany).
2.7. Statistical Analysis
Statistical analysis of the obtained results was performed using GraphPad Prism v.9.0
(Trial version, GraphPad Software, CA, USA). Data are presented as the mean ± standard
deviation (s.d.). One-way analysis of variance (ANOVA) with the Student–Newman–
Keuls test was used to compare different groups. A value of p < 0.05 was considered
statistically significant.
3. Results and Discussion
3.1. Evaluation of the GSH Effect on the Agglomeration of Gold Nanoparticles
This work aimed to develop and optimize a new method to produce gold nanoclusters
containing a mesoporous silica shell. The AuMSS nanoclusters production is divided
into three main phases (as demonstrated in Figure 1 schematics): (i) synthesis of the gold
nanospheres; (ii) agglomeration of gold nanospheres; and (iii) production of the meso-
porous silica layer. The gold nanospheres are synthesized by promoting the reduction
of gold in the presence of formaldehyde [40]. Afterward, GSH was selected to mediate
the nanospheres agglomeration due to previous evidence in literature that compounds
containing amine and thiol functional groups can trigger the aggregation of gold nanopar-
ticles [34]. Finally, the mesoporous silica shell was produced via TEOS hydrolysis in the
presence of CTAB.
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Figure 2. AuMSS nanoclusters morphology and UV-Vis-NIR data analysis. (A) TEM images of
Formula A; (B) Formula B; (C) Formula C; (D) Formula D and (E) Formula E AuMSS nanoclusters.
(F) UV-Vis-NIR spectra of different nanoformulations of AuMSS nanoclusters. Scale bar: 200 nm.
3.2. Optimization of the Mesoporous Silica Shell
The introduction of a mesoporous silica shell can also impact the physicochemical
properties of the gold nanoparticles [45]. With that in mind, the mesoporous silica coating
was optimized by fine-tuning the TEOS concentration. For that purpose, gold nanoclusters
produced using 3.5 or 5 mL of GSH (6.13 mg/mL) were reacted with 0.200, 0.100, or
0.50 mL of TEOS (33% v/v in ethanol). The Formula B, G and F refer to the AuMSS
nanoclusters produced using 3.5 mL of GSH (6.13 mg/mL) and 0.200, 0.100, or 0.50 mL
of TEOS, respectively, whereas the Formula E, I and H represent the ones resulting from
5 mL of GSH (6.13 mg/mL) and 0.200, 0.100, or 0.50 mL of TEOS, respectively. The
produced Formula B, E, F, G, H and I AuMSS nanoclusters were characterized by DLS
to assess their size and particle distribution, Figure 3. The AuMSS nanoclusters have a
homogeneous population and the reduction in the TEOS amount lead to a decrease in
the nanoparticles’ mean size. The AuMSS nanoclusters produced with 3.5 mL of GSH
presented a mean diameter of 267.74, 202.86 and 136 nm for Formula B, F and G, respectively.
Otherwise, Formula E, H and I nanoclusters presented a mean diameter of 109.20, 91.58
and 89.67 nm, respectively. This size reduction within each nanocluster group might
be justified by the reduction of the mesoporous silica shell thickness in response to the
decrease in the silica source, i.e., TEOS, during the synthesis process. Additionally, this
TEOS optimization also originates nanomaterials with size within the range considered
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ideal for intravenous administration (i.e., 100 to 200 nm), which is crucial for exploiting the
leaky structure of the tumoral vasculature, i.e., the enhanced permeability and retention
(EPR) effect [45,46]. Otherwise, surface charge measurements showed that all the different
formulations present a negative surface charge (Figure 3G). This negative surface charge
is characteristic of silica-based materials due to the silanol groups available at the surface
of the AuMSS nanoclusters [47,48]. Additionally, the results are also indicative of the
successful removal of the cationic CTAB molecules used both as structure-directing agents
for the pores formation and surfactant for maintaining the stability of the particles [49,50].
Furthermore, nanomaterials with slightly negative surface charges often exhibit increased
blood circulation times [51].




Figure 3. Physicochemical characterization of AuMSS nanoclusters formulations. (A)The size distribution of Formula B; 
(B) Formula E; (C) Formula F; (D) Formula G; (E) Formula H and (F) Formula I, n = 300. (G) Analysis of the AuMSS 
nanoclusters’ surface charge, n = 3. 
Figure 3. Physicochemical characterization of AuMSS nanocluste s formulations. (A) The size
distribution of Formula B; (B) Formula E; (C) Formula F; (D) Formula G; (E) Formula H and (F)
Formula I, n = 300. (G) Analysis of the AuMSS nanoclusters’ surface charge, n = 3.
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3.3. In Vitro Evaluation of the AuMSS Nanoclusters Photothermal Capacity
The AuMSS nanoclusters’ ability to act as a photothermal agent was initially evaluated
by measuring the UV-Vis-NIR absorption of Formula B, E, F, G, H and I (Figure 4A). As
previously observed, the organization of gold nanospheres into nanoclusters induce a
redshift in the absorption peak and enhance the overall absorption at the 700–800 nm
region. Particularly, Formula G, H and I nanoclusters have a higher absorption in the
500 to 800 nm region with a broad absorption peak. Moreover, the obtained data also
show that decreasing the TEOS amount during the AuMSS nanocluster synthesis further
increases the NIR absorption. The analysis of the absorption spectra revealed that in the
AuMSS nanoclusters produced with 3.5 mL of GSH, the TEOS reduction from 0.200 to 0.100
and 0.050 mL (Formula B, G and F) enhanced the absorption at 808 nm in 403 and 154%,
respectively. Similar results were observed in the AuMSS nanoclusters produced with 5 mL
of GSH with a 363 and 311% increase in the absorption at 808 nm for the Formula H and I,
respectively. Considering the different formulations of AuMSS nanoclusters, it is possible
to conclude that Formula H AuMSS nanoclusters (i.e., 5 mL of GSH and 0.050 mL of TEOS)
are the ones presenting the highest NIR absorption. Nevertheless, these data support the
applicability of the AuMSS nanoclusters in PTT applications.
Nanomaterials 2021, 11, x FOR PEER REVIEW 9 of 16 
 
 
3.3. In Vitro Evaluation of the AuMSS Nanoclusters Photothermal Capacity 
The AuMSS nanoclusters’ ability to act as a photothermal agent was initially evalu-
ated by measuring the UV-Vis-NIR absorption of Formula B, E, F, G, H and I (Figure 4A). 
As previously observed, the organization of gold nanospheres into nanoclusters induce a 
redshift in the absorption peak and enhance the overall absorption at the 700–800 nm re-
gion. Particularly, Formula G, H and I nanoclusters have a higher absorption in the 500 to 
800 nm region with a broad absorption peak. Moreover, the obtained data also show that 
decreasing the TEOS amount during the AuMSS nanocluster synthesis further increases 
the NIR absorption. The analysis of the absorption spectra revealed that in the AuMSS 
nanoclusters produced with 3.5 mL of GSH, the TEOS reduction from 0.200 to 0.100 and 
0.050 mL (Formula B, G and F) enhanced the absorption at 808 nm in 403 and 154%, re-
spectively. Similar results were observed in the AuMSS nanoclusters produced with 5 mL 
of GSH with a 363 and 311% increase in the absorption at 808 nm for the Formula H and 
I, respectively. Considering the different formulations of AuMSS nanoclusters, it is possi-
ble to conclude that Formula H AuMSS nanoclusters (i.e., 5 mL of GSH and 0.050 mL of 
TEOS) are the ones presenting the highest NIR absorption. Nevertheless, these data sup-
port the applicability of the AuMSS nanoclusters in PTT applications. 
The AuMSS nanoclusters’ photothermal capacity was investigated by recording the 
temperature changes in response to the nanom terials’ irradiation with NIR l ght (808 nm, 
1.7 W cm−2) for 10 min (Figure 4B). The obtained es lts demonstrated that all the AuMSS 
nanoclusters can g nerat  heat and increase the temperature of the surrounding media in 
response to the NIR laser. In this regard, Formula B and E (0.200 mL of TEOS) induced 
the smallest ncrease in te perature, i.e., ΔT≈ 8 °C. O herwise, the NIR laser ir ad atio  of 
the Formula H and I AuMSS nanoclusters resulted in the highest emperature increase, 
ΔT≈ 20 n  13 °C, respectively. In tur , the Formula F and G AuMSS nanoclusters p o-
moted an increase in the temperature of ≈ 11 °C. Despite the e differences, all AuMSS 
nanoclusters pres nted similar heating profiles, with a pronounced rise in the temperature 
i  the first 5 min of irradiation follow d by a temp rature s abilization unt l the end of the 
x rim nt. It is worth to not  that the differences observed in the heating capacity of the 
different AuMSS nanoclusters a  in accord nce with the results previously obtained in 
the absorption spectra. More impo tantly, the heat generated in resp nse o the NIR la er 
indicates that these A MSS nanoclusters may induc  the death of cancer cells through the 
cell membrane’  disruption, DNA damages and alterations on the metabolic pathways 
[6]. 
 
Figure 4. Characterization of the PTT capacity of AuMSS nanoclusters. (A) UV-Vis-NIR spectra of 
different nanoformulations of AuMSS nanoclusters; (B) Temperature variation curves of AuMSS 
nanoclusters in ultrapure water, NIR laser (808 nm, 1.7 W cm−2) irradiation for 10 min. Data are 
presented as mean ± s.d., * p < 0.05, n = 3. 
  
Figure 4. Characterization of the PTT capacity of AuMSS nanoclusters. (A) UV-Vis-NIR spectra of
different na f r l ti s f SS nanoclusters; (B) Temperature variation curves of AuMSS
nanocl t i l , . 2) irradiation for 10 min. D t are
presented as ean s.d., n = 3.
The AuMSS nanoclusters’ photothermal capacity was investigated by recording the
temperature changes in response to the nanomaterials’ irradiation with NIR light (808 nm,
1.7 W cm−2) for 10 min (Figure 4B). The obtained results demonstrated that all the AuMSS
nanoclusters can generate heat and increase the temperature of the surrounding media in
response to the NIR laser. In this regard, Formula B and E (0.200 mL of TEOS) induced the
smallest increase in temperature, i.e., ∆T ≈ 8 ◦C. Otherwise, the NIR laser irradiation of
the Formula H and I AuMSS nanoclusters resulted in the highest temperature increase,
∆T ≈ 20 and 13 ◦C, respectively. In turn, the Formula F and G AuMSS nanoclusters
promoted an increase in the temperature of ≈11 ◦C. Despite these differences, all AuMSS
nanoclusters presented similar heating profiles, with a pronounced rise in the temperature
in the first 5 min of irradiation followed by a temperature stabilization until the end of the
experiment. It is worth to note that the differences observed in the heating capacity of the
different AuMSS nanoclusters are in accordance with the results previously obtained in
the absorption spectra. More importantly, the heat generated in response to the NIR laser
indicates that these AuMSS nanoclusters may induce the death of cancer cells through the
cell membrane’s disruption, DNA damages and alterations on the metabolic pathways [6].
3.4. AuMSS Nanoclusters Cytocompatibility
The cytocompatibility of AuMSS nanoclusters was evaluated both on FibH and HeLa
cells (Figure S2). For that purpose, the resazurin assay was used to evaluate the impact of
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the AuMSS nanoclusters (concentrations ranging from 50 up to 200 µg/mL) on the cellular
viability after 24, 48 and 72 h. Figure S2 shows that the AuMSS nanoclusters formulations
are biocompatible with both cell lines, cell viability superior to 70%, even at the highest
tested concentration of 200 µg/mL. Therefore, these data further support the effectiveness
of the purification step and consequent removal of CTAB from the AuMSS nanoclusters.
It is worth noticing that the CTAB is highly cytotoxic, even more than doxorubicin (an
anticancer drug with a broad spectrum of activity) [52,53]. Moreover, this cytocompatibility
profile is in concordance with other reports for nanomedicines based on gold core-silica
shell-nanoparticles [54,55].
3.5. Photothermal Effect Mediated by AuMSS Nanoclusters
The Formula F, G, H and I were selected to evaluate the PTT potential of AuMSS
nanoclusters since these formulations presented the best results in the in vitro photothermal
measurements. The AuMSS nanoclusters cytotoxic profile towards HeLa cells was assessed
upon 1 or 3 cycles of irradiation with NIR light (Figure 5). The obtained results show that
the heat generated by the AuMSS nanoclusters in response to the NIR laser irradiation
leads to the reduction of the HeLa cells’ viability. Moreover, the increase in the number of
NIR laser irradiation cycles further enhanced the cytotoxic effect of AuMSS nanoclusters.
It is worth noticing that the highest reduction in the HeLa cells viability was achieved
with Formula H and I AuMSS nanoclusters, reaching viabilities inferior to 25% and 60%
after 3 cycles of irradiation, respectively. These data are in agreement with the in vitro
photothermal measurements, where these two formulations mediated the highest increase
in the media temperature. Hyperthermia treatments that reach temperatures above 45 ◦C
can induce the death of cancer cells by causing irreversible damages to DNA, protein
denaturation and the rupture of cell membranes [56].
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The Live/Dead assay further confirmed the AuMSS nanoclusters’ photothermal
therapeutic effect. In this assay, after incubation with the different AuMSS nanocluster
formulations and 1 or 3 cycles of irradiation with NIR light, the HeLa cells were stained with
Calcein AM and PI. In Figure 6, it is possible to observe in the NIR laser-irradiated region a
large area of dead cells (i.e., red fluorescence). Furthermore, it is possible to observe that
the area of dead cells increases with the number of irradiation cycles, supporting the data
obtained in the resazurin assays. Therefore, the reduction of the HeLa cells viability and
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the Live/Dead images confirm that the AuMSS nanoclusters can mediate an on-demand
NIR light-triggered photothermal therapeutic effect.
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Figure 6. Cytotoxic effect of AuMSS nanoformulations in HeLa cells. Live/Dead CLSM images of
the cytotoxic activity of different nanoclusters at 200 µg/mL with 1 and 3 laser irradiations. Green
Channel: Calcein stained cells; Red channel: PI-stained cells. Scale bar: 200 µm.
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Moreover, as demonstrated in Figure S3, the AuMSS nanoclusters can also act as drug
delivery systems. Considering the mesoporous structure of AuMSS nanoclusters, Formula
H and I (formulations with the best photothermal effect) were selected to evaluate the drug
loading capacity using AO as a drug model. Formula H and I AuMSS nanoclusters achieved
AO encapsulation efficiencies of 72 and 75%, which correspond to the encapsulation of
26 and 30 µg of AO per mg of nanoparticles, respectively. Additionally, the AuMSS
nanoclusters showed a similar release profile both at pH 7.4 and 5.6, with a burst release
in the initial 8 h followed by a sustained and controlled release, reaching the maximum
after 48 h. These findings support the future application of these AuMSS nanoclusters
in combinatorial therapy (PTT and chemotherapy), allowing the development of more
effective anticancer nanomedicines.
4. Conclusions
The unique physicochemical and biological properties of AuMSS nanoparticles
prompted the application and development of new nanoplatforms for cancer therapy.
The core-shell organization of AuMSS allows the combination of the imaging and pho-
tothermal capacity of gold nanomaterials with the superior stability and drug loading
ability of mesoporous silica.
With that in mind, a new methodology was herein optimized to produce AuMSSs
composed of a core of gold nanoclusters, for being applied as photothermal agents in cancer
therapy. The development of the AuMSS nanoclusters was based on the optimization
of two main parameters, the amount of GSH (i.e., the agent responsible for mediating
the gold nanospheres aggregation) and silica source (i.e., TEOS). The obtained results
revealed that the increase in the nanoclusters formation and the absorption capacity in the
700–800 nm with crescent amounts of GSH. Then, the production of mesoporous silica was
optimized for the two selected formulations of AuMSS nanoclusters (Formula B and E).
The reduction in the silica source (from 0.200 to 0.100 and 0.050 mL) during the AuMSS
nanoclusters synthesis resulted in the fine-tuning of the nanomaterials’ size to values
within the range considered ideal for intravenous administration (i.e., 100 to 200 nm).
Furthermore, it was also observed a significant enhancement in the absorption capacity
at 808 nm, 1.5–4 times higher, in the Formula G, F, H and I AuMSS nanoclusters. These
improvements resulted in higher photothermal capacities, reaching the maximum ∆T
of ≈20 and 13 ◦C with the Formula H and I, respectively. These translated to an on-
demand NIR laser-triggered photothermal effect that induced the death of HeLa cancer
cells, which was further enhanced when multiple irradiations were used. Overall, these
data support the development of AuMSS nanoclusters as PTT agents, particularly Formula
H, which combined with the gold bioimaging and mesoporous silica drug-loading capacity
can be further explored to develop a multifunctional nanomedicine with an enhanced
anticancer capacity.
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